来自患者iPSC的亚型特定神经元显示出阿尔茨海默氏症疾病的独特神经病理特征
Ran Tao1, Chunmei Yue2, Zhijie Guo3,4
1Guangzhou National Laboratory, Guangzhou International Bio Island, No. 9 Xing Dao Huan Bei Road, Guangdong Province, 510005, China. tao_ran@gzlab.ac.cn.
Cell regeneration (London, England)
|October 10, 2024
概括
阿尔茨海默病 (AD) 影响特定的大脑神经元不同. 来自患者的模型显示,基础前脑胆能神经元 (BFCNs) 和皮质神经元对粉样β有独特的反应,影响AD进展.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 阿尔茨海默病 (AD) 导致渐进的神经退行,选择性地影响皮质的谷氨基基和基础前脑胆固醇神经元 (BFCNs).
- 了解早期的AD病原体对于开发干预措施至关重要,但对患者神经元的直接研究是有限的.
- 神经元亚型的脆弱性和对AD早期病理性压力的反应仍然不清楚.
研究的目的:
- 在特定的神经元亚型中调查阿尔茨海默氏症 (AD) 病原发生的独特细胞和分子机制.
- 建立和利用患者衍生的诱导多能干细胞 (iPSCs) 来在皮层谷氨基基神经元和基础前脑胆固醇神经元 (BFCNs) 中建模早期的AD.
- 为了比较这些神经元亚型对粉样β oligomer (AβO) 暴露的不同反应.
主要方法:
- 开发了体外分化系统,以从患者衍生的iPSC产生BFCN.
- 培养和处理由iPSC衍生的皮质谷氨基基质神经元和带有Aβ42寡合体 (AβO) 的BFCN.
- 分析了Aβ分泌,陶酸化,亡以及神经元亚型的电生理学特性.
主要成果:
- 与皮层神经元相比,来自AD患者的BFCN分泌的Aβ较少,Aβ42/Aβ40比率相似.
- 与皮层神经元相比,BFCN对AβO诱导的 fosforylation和表达的敏感性较低.
- 在AD-皮层谷氨基质神经元和AD-BFCN中,AβO触发了亡,在亚型之间观察到不同的电生理反应和AβO敏感性.
结论:
- 阿尔茨海默病 (AD) 中的亚型特定神经元表现出明显的神经病理变化和对粉样β oligomer (AβO) 压力的反应.
- 这些发现凸显了考虑神经元亚型异质性在理解AD病变发生过程中的重要性.
- 来自患者的iPSC模型为AD的早期细胞机制提供了宝贵的见解.
更多相关视频
相关概念视频
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


